The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Ureter Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Ureter Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer - Drugs In Development, 2021, provides a...
August 2021
516 pages
Global Penicillin Drug Market by Product (Bulk and Dosage), Type (Aminopenicillin, Antipseudomonal Penicillin, Beta-lactamase Inhibitor, Natural Penicillin, and Penicillinase-resistant Penicillin), Manufacturing Process (Synthetic Process, Natural Process, and Semisynthetic Process), Mode of Delivery (Oral, Intramuscular, and Intravenous), and End User (Hospitals, Clinics, Research Institutes, and Others), Regional Forecasts 2021-2027
US$ 3,218.00
Global Penicillin Drug Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Penicillin is...
August 2021
200 pages
Global Vitamin Deficiency Treatment Market Size study, by Product (OTC Multivitamin Therapies, Single Vitamin Therapies, Vitamin A Supplements, Vitamin B Complex Supplements, Vitamin D Supplements and Others), End User (Pharmacy and Drugstores, Hospital Pharmacy, Online Drug Stores or Email Prescription Stores, Hypermarkets and Supermarkets), and Regional Forecasts 2021-2027
US$ 3,218.00
Global Vitamin Deficiency Treatment Market is valued approximately USD xx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2021-2027. Vi...
August 2021
200 pages
Global Markets and Manufacturing Technologies for Protein Drugs
US$ 2,750.00
The global protein drugs market reached nearly $174.7 billion in 2015 and should reach nearly $ ... annual growth rate (CAGR) of 7.3% through 2020. The U.S., leader in the protein drugs market, reached nearly $92.0 billion in 2015 and should reach $154.1 billion ...
August 2021
159 pages
India Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, FY2027
US$ 4,400.00
India anti-fungal drugs market is expected to reach USD1562.73 million by FY2027, growing at a double digit CAGR of 10.49% over the forecast period. Increasing prevalence of fungal infections such as...
August 2021
77 pages
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...
July 2021
63 pages
Acne Vulgaris (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Acne Vulgaris (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Drugs In Development, 2021, provide...
July 2021
252 pages
Adenosine Receptor A3 - Drugs In Development, 2021
US$ 3,500.00
Adenosine Receptor A3 - Drugs In Development, 2021 SUMMARY Adenosine Receptor A3 (ADORA3) - The adenosine A3 receptor, also known as ADORA3, is an adenosine receptor. Adenosine A3 receptors are G prot...
July 2021
96 pages
Anal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Anal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Drugs In Development, 2021, provides an ov...
July 2021
813 pages
Blepharitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Blepharitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Drugs In Development, 2021, provides...
July 2021
79 pages
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8...
July 2021
63 pages
Cat Allergy (Immunology) - Drugs In Development, 2021
US$ 2,000.00
Cat Allergy (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Drugs In Development, 2021, provides an...
July 2021
35 pages
Chemotherapy Induced Anemia - Drugs In Development, 2021
US$ 2,000.00
Chemotherapy Induced Anemia - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Drugs In Development,...
July 2021
77 pages
Cough (Respiratory) - Drugs In Development, 2021
US$ 2,000.00
Cough (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cough - Drugs In Development, 2021, provides an overview of...
July 2021
132 pages
